{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:13:15Z","timestamp":1788351195148,"version":"build-2803163510"},"reference-count":50,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi221117-4\"><jats:title>Importance<\/jats:title><jats:p>During menopause, the levels of estrogen and progesterone decrease and 60% to 70% of women experience menopausal symptoms, including mood disturbances. The latter might be prevented by hormone therapy (HT), yet some studies have suggested that use of HT might be associated with increased risk of depression.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221117-5\"><jats:title>Objective<\/jats:title><jats:p>To examine whether use of HT during menopause was associated with a subsequent diagnosis of depression.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221117-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This nationwide register\u2013based cohort and self-controlled case series study included all women in Denmark aged 45 years between January 1, 1995, through December 31, 2017 (n\u2009=\u2009825 238), without prior oophorectomy, breast cancer, or cancer in reproductive organs. Follow-up was completed on December 31, 2018. The statistical analysis was performed from September 1, 2021, through May 31, 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221117-7\"><jats:title>Exposures<\/jats:title><jats:p>Redeemed prescriptions of different types of HT identified by the Anatomical Therapeutic Chemical classification system codes (G03C [estrogen] and G03F [estrogen combined with progestin]) in the Danish National Prescription Registry between 1995 and 2017. Type of administration was divided into systemic (oral or transdermal) and local (intravaginal or intrauterine).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221117-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>A hospital diagnosis of depression (<jats:italic>International Statistical Classification of Diseases and Related Health Problems, Tenth Revision<\/jats:italic>, codes F32-F33 and <jats:italic>International Classification of Diseases, Eighth Revision<\/jats:italic>, codes 296.09, 296.29, 298.0, and 300.49) between 1995 through 2018. Associations were examined in cohort and self-controlled case series analysis using Cox proportional hazards and fixed-effects Poisson regression models.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221117-9\"><jats:title>Results<\/jats:title><jats:p>During follow-up from 45 years of age to a mean of 56.0 (range, 45.1-67.7) years, 189 821 women (23.0%) initiated systemically or locally administered HT and 13\u202f069 (1.6%) were diagnosed with depression. Systemically administered HT was mainly initiated before 50 years of age and was associated with a higher risk of a subsequent depression diagnosis (hazard ratio [HR] for 48-50 years of age, 1.50 [95% CI, 1.24-1.81]). The risk was especially elevated the year after initiation of both treatment with estrogen alone (HR, 2.03 [95% CI, 1.21-3.41]) and estrogen combined with progestin (HR, 2.01 [95% CI,1.26-3.21]). Locally administered HT was initiated across all ages and was not associated with depression risk (HR, 1.15 [95% CI, 0.70-1.87]). It was, however, associated with a lower risk of depression when initiated after 54 years of age (HR for 54-60 years of age, 0.80 [95% CI, 0.70-0.91]). In self-controlled analysis, which efficiently accounts for time-invariant confounding, users of systemically administered HT had higher rates of depression in the years after initiation compared with the years before treatment (incidence rate ratio for 0-1 year after initiation, 1.66 [95% CI, 1.30-2.14]).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221117-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>These findings suggest that systemically administered HT before and during menopause is associated with higher risk of depression, especially in the years immediately after initiation, whereas locally administered HT is associated with lower risk of depression for women 54 years or older.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.39491","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T15:02:59Z","timestamp":1667314979000},"page":"e2239491","source":"Crossref","is-referenced-by-count":33,"title":["Association of Hormone Therapy With Depression During Menopause in a Cohort of Danish Women"],"prefix":"10.1001","volume":"5","author":[{"given":"Marie K.","family":"Wium-Andersen","sequence":"first","affiliation":[{"name":"Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospitals, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terese S. H.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospitals, Frederiksberg, Denmark"},{"name":"Department of Public Health, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniken H.","family":"Halvorsen","sequence":"additional","affiliation":[{"name":"Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospitals, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte H.","family":"Hartsteen","sequence":"additional","affiliation":[{"name":"Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospitals, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Psychiatric Centre Copenhagen, Rigshospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Osler","sequence":"additional","affiliation":[{"name":"Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospitals, Frederiksberg, Denmark"},{"name":"Department of Public Health, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"issue":"10258","key":"zoi221117r1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"zoi221117r2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.puhe.2009.09.010","article-title":"Gender-related explanatory models of depression: a critical evaluation of medical articles.","volume":"123","author":"Hammarstr\u00f6m","year":"2009","journal-title":"Public Health"},{"issue":"9","key":"zoi221117r3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0006-3223(98)00169-3","article-title":"Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?","volume":"44","author":"Joffe","year":"1998","journal-title":"Biol Psychiatry"},{"key":"zoi221117r4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.psyneuen.2014.07.025","article-title":"Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review.","volume":"50","author":"Toffoletto","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"zoi221117r5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1503\/jpn.150205","article-title":"Why is depression more prevalent in women?","volume":"40","author":"Albert","year":"2015","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"zoi221117r6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archpsyc.61.1.62","article-title":"Hormones and menopausal status as predictors of depression in women in transition to menopause.","volume":"61","author":"Freeman","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"zoi221117r7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jamapsychiatry.2013.2819","article-title":"Longitudinal pattern of depressive symptoms around natural menopause.","volume":"71","author":"Freeman","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"zoi221117r8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jsbmb.2013.06.001","article-title":"Cognition and mood in perimenopause: a systematic review and meta-analysis.","volume":"142","author":"Weber","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"zoi221117r9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/GME.0000000000000193","article-title":"Mood disorders in midlife women: understanding the critical window and its clinical implications.","volume":"21","author":"Soares","year":"2014","journal-title":"Menopause"},{"key":"zoi221117r10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jad.2016.07.040","article-title":"Depression during the perimenopause: a meta-analysis.","volume":"206","author":"de Kruif","year":"2016","journal-title":"J Affect Disord"},{"issue":"4-5","key":"zoi221117r11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000012289","article-title":"Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures.","volume":"67","author":"Bech","year":"1998","journal-title":"Psychother Psychosom"},{"issue":"2","key":"zoi221117r12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1210\/jcem.86.2.7179","article-title":"Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause.","volume":"86","author":"Paoletti","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"zoi221117r13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0378-5122(02)00327-4","article-title":"Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women.","volume":"44","author":"Gambacciani","year":"2003","journal-title":"Maturitas"},{"issue":"2","key":"zoi221117r14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamapsychiatry.2017.3998","article-title":"Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial.","volume":"75","author":"Gordon","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"zoi221117r15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1067\/mob.2000.106004","article-title":"Estrogen replacement in perimenopause-related depression: a preliminary report.","volume":"183","author":"Schmidt","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"zoi221117r16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1620\/tjem.207.223","article-title":"Mood scores in relation to hormone replacement therapies during menopause: a prospective randomized trial.","volume":"207","author":"Onalan","year":"2005","journal-title":"Tohoku J Exp Med"},{"issue":"8","key":"zoi221117r17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/da.2015.32.issue-8","article-title":"Efficacy of estradiol in perimenopausal depression: so much promise and so few answers.","volume":"32","author":"Rubinow","year":"2015","journal-title":"Depress Anxiety"},{"issue":"4","key":"zoi221117r18","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.fertnstert.2014.02.025","article-title":"Effects of hormone therapy on cognition and mood.","volume":"101","author":"Fischer","year":"2014","journal-title":"Fertil Steril"},{"issue":"19","key":"zoi221117r19","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1056\/NEJMoa030311","article-title":"Effects of estrogen plus progestin on health-related quality of life.","volume":"348","author":"Hays","year":"2003","journal-title":"N Engl J Med"},{"key":"zoi221117r20","doi-asserted-by":"publisher","first-page":"a1190","DOI":"10.1136\/bmj.a1190","article-title":"Health related quality of life after combined hormone replacement therapy: randomised controlled trial.","volume":"337","author":"Welton","year":"2008","journal-title":"BMJ"},{"issue":"10","key":"zoi221117r21","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/GME.0000000000001131","article-title":"Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.","volume":"25","author":"Diem","year":"2018","journal-title":"Menopause"},{"issue":"2-3","key":"zoi221117r22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0378-5122(94)90005-1","article-title":"Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study.","volume":"20","author":"Collins","year":"1994","journal-title":"Maturitas"},{"issue":"2","key":"zoi221117r23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0378-5122(99)00093-6","article-title":"Hormonal substitution during menopause: what are we treating?","volume":"34","author":"Maartens","year":"2000","journal-title":"Maturitas"},{"issue":"6","key":"zoi221117r24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/gme.0b013e318278eec1","article-title":"Associations between psychological well-being, mental health, and hormone therapy in perimenopausal and postmenopausal women: results of two population-based studies.","volume":"20","author":"Toffol","year":"2013","journal-title":"Menopause"},{"key":"zoi221117r25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jad.2015.09.068","article-title":"Suicidal ideation among postmenopausal women on hormone replacement therapy: the Korean National Health and Nutrition Examination Survey (KNHANES V) from 2010 to 2012.","volume":"189","author":"Lee","year":"2016","journal-title":"J Affect Disord"},{"issue":"7","key":"zoi221117r26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/GME.0000000000001540","article-title":"Depression, hormone therapy, and the menopausal transition among women aged 45 to 64 years using Canadian Longitudinal Study on Aging baseline data.","volume":"27","author":"Shea","year":"2020","journal-title":"Menopause"},{"issue":"8","key":"zoi221117r27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1046\/j.1525-1497.2000.04029.x","article-title":"Postmenopausal estrogen therapy and depressive symptoms in older women.","volume":"15","author":"Whooley","year":"2000","journal-title":"J Gen Intern Med"},{"issue":"3","key":"zoi221117r28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1037\/0022-006X.58.3.345","article-title":"Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women.","volume":"58","author":"Matthews","year":"1990","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"zoi221117r29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/1047-2797(94)90099-X","article-title":"A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women\u2019s Health Study.","volume":"4","author":"Avis","year":"1994","journal-title":"Ann Epidemiol"},{"issue":"3","key":"zoi221117r30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/gme.0b013e31814faf2b","article-title":"The impact of hormone therapy on health-related quality of life: longitudinal results from the Study of Women\u2019s Health Across the Nation.","volume":"15","author":"Hess","year":"2008","journal-title":"Menopause"},{"issue":"12","key":"zoi221117r31","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/GME.0000000000000712","article-title":"Depressive symptoms across the menopause transition: findings from a large population-based cohort study.","volume":"23","author":"Hickey","year":"2016","journal-title":"Menopause"},{"issue":"11","key":"zoi221117r32","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0277-9536(01)00326-4","article-title":"Change in psychological and vasomotor symptom reporting during the menopause.","volume":"55","author":"Hardy","year":"2002","journal-title":"Soc Sci Med"},{"issue":"4","key":"zoi221117r33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/archpsyc.63.4.385","article-title":"Risk for new onset of depression during the menopausal transition: the Harvard Study of Moods and Cycles.","volume":"63","author":"Cohen","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"zoi221117r34","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.4088\/JCP.09m05188blu","article-title":"A prospective study of hormone therapy and depression in community-dwelling elderly women: the Three City Study.","volume":"71","author":"Scali","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"zoi221117r35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence.","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"zoi221117r36","first-page":"441","article-title":"The Danish Civil Registration System: a cohort of eight million persons.","volume":"53","author":"Pedersen","year":"2006","journal-title":"Dan Med Bull"},{"key":"zoi221117r37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential.","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"3","key":"zoi221117r38","first-page":"798","article-title":"Data resource profile: the Danish National Prescription Registry.","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"5","key":"zoi221117r39","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/ije\/dyw116","article-title":"Data resource profile: Danish Online Drug Use Statistics (MEDSTAT).","volume":"45","author":"Schmidt","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"7","key":"zoi221117r40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1403494810395825","article-title":"The Danish Psychiatric Central Research Register.","volume":"39","author":"Mors","year":"2011","journal-title":"Scand J Public Health"},{"key":"zoi221117r41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1192\/bjp.172.1.23","article-title":"Recurrence in affective disorder, I: case register study.","volume":"172","author":"Kessing","year":"1998","journal-title":"Br J Psychiatry"},{"issue":"3","key":"zoi221117r42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/wps.v20.3","article-title":"Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas.","volume":"20","author":"Arango","year":"2021","journal-title":"World Psychiatry"},{"issue":"5","key":"zoi221117r43","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/GME.0000000000000323","article-title":"Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review.","volume":"22","author":"Toffol","year":"2015","journal-title":"Menopause"},{"issue":"7","key":"zoi221117r44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1403494811399956","article-title":"Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving.","volume":"39","author":"Thygesen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"1","key":"zoi221117r45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","article-title":"The Danish Medical Birth Register.","volume":"33","author":"Bliddal","year":"2018","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"zoi221117r46","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1080\/00016340701505523","article-title":"Hormone replacement therapy in Denmark, 1995-2004.","volume":"86","author":"L\u00f8kkegaard","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"10","key":"zoi221117r47","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Tutorial in biostatistics: the self-controlled case series method.","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"issue":"6","key":"zoi221117r48","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/aje\/kwn364","article-title":"Use of self-controlled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes.","volume":"169","author":"Gibson","year":"2009","journal-title":"Am J Epidemiol"},{"key":"zoi221117r49","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1097\/MLR.0000000000001433","article-title":"Menopausal hormone therapy and suicide in a national sample of midlife and older women veterans.","volume":"59","author":"Gibson","year":"2021","journal-title":"Med Care"},{"issue":"6","key":"zoi221117r50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001833","article-title":"Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-Cognitive and Affective Study.","volume":"12","author":"Gleason","year":"2015","journal-title":"PLoS Med"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2798003\/wiumandersen_2022_oi_221117_1666637052.78827.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T15:03:04Z","timestamp":1667314984000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2798003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.39491","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}